Prospective study of urinary excretion of 7-methylguanine and the risk of lung cancer: Effect modification by mu class glutathione-S-transferases.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractNitrosamines are mainly mutagenic through methylation of DNA. 7-Methylguanine (m(7)Gua) is a product of base excision repair and spontaneous depurination of such lesions in DNA and a metabolite from RNA. Associations between urinary excretion of m(7)Gua and risk of lung cancer were examined in a population-based cohort of 25,717 men and 27,972 women aged 50-64 years. During 3-7 years follow-up 260 cases with lung cancer were identified and a subcohort of 263 individuals matched on sex, age and smoking duration was selected for comparison. Urine collected at entry was analyzed for m(7)Gua by HPLC. Effect modification by glutathione-S-transferases GSTM1, GSTM3, GSTT1 and GSTP1 was investigated. We found higher excretion of m(7)Gua among current smokers than among former smokers. The IRR (incidence rate ratio) of lung cancer was 1.20 (95% CI: 1.00-1.43) per doubling of m(7)Gua excretion in unadjusted analysis and 1.12 (95% CI: 0.93-1.35) after adjustment for smoking status, intensity and duration at entry. This association was mainly present among current smokers. Comparing the highest with the lowest tertile of m(7)Gua excretion the IRR of lung cancer was 1.75 (95% CI: 1.04-2.95) irrespective of genotype and 2.75 (95% CI: 1.33-5.81) in subjects with GSTM1 null genotype. If not caused by residual confounding by smoking a possible association between m(7)Gua excretion and lung cancer supports the importance of methylation of guanine. The finding of an association between m(7)Gua excretion and lung cancer risk mainly among current smokers and subjects with GSTM1 null genotype supports causality in this respect.
CitationInt. J. Cancer 2007, 121 (7):1579-1584
SponsorsFunded by: Danish Research Councils, Danish Cancer Society, Japan Society for the Promotion of Science and ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence under the European Union 6th Framework Program Priority 5: Food Quality and Safety; Grant Number: 513943
- GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
- Authors: Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V, Simic T
- Issue date: 2013 Oct
- Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study.
- Authors: Loft S, Svoboda P, Kawai K, Kasai H, Sørensen M, Tjønneland A, Vogel U, Møller P, Overvad K, Raaschou-Nielsen O
- Issue date: 2012 Jan 1
- Modification of urinary N7-methylguanine excretion in smokers by glutathione-S-transferase M1 polymorphism.
- Authors: Lin IH, Chao MR, Hu CW, Ho ML, Huang JY, Lee HS, Chen CC, Wong RH
- Issue date: 2009 Jun 16
- Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer.
- Authors: Sørensen M, Autrup H, Tjønneland A, Overvad K, Raaschou-Nielsen O
- Issue date: 2004 Jun 10
- GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
- Authors: Schneider J, Bernges U, Philipp M, Woitowitz HJ
- Issue date: 2004 May 10